Results 151 to 160 of about 8,627 (176)

Dabigatran etexilate

Reactions Weekly, 2021
openaire   +2 more sources

Dabigatran etexilate

Reactions Weekly, 2017
openaire   +1 more source

Development and validation of LC–MS/MS method for simultaneous determination of dabigatran etexilate and its active metabolites in human plasma, and its application in a pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis, 2021
Jin-Woo Park, Hyewon Chung, Kyoung-Ah Kim   +2 more
exaly  

Dabigatran etexilate

Reactions Weekly, 2012
openaire   +2 more sources

Dabigatran etexilate

Reactions Weekly, 2011
openaire   +2 more sources

Decrease in the oral bioavailability of dabigatran etexilate after co‐medication with rifampicin

British Journal of Clinical Pharmacology, 2012
Gerhard Nehmiz
exaly  

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

Clinical Pharmacokinetics, 2012
Joachim Stangier
exaly  

Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

Clinical and Applied Thrombosis/Hemostasis, 2009
Andreas Clemens, Joachim Stangier
exaly  

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Thrombosis and Haemostasis, 2010
Andreas Clemens, Martin Feuring, Joanne van Ryn   +2 more
exaly  

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate

Clinical Pharmacokinetics, 2012
Joachim Stangier
exaly